10,175
Total Claims
$2.6M
Drug Cost
1,313
Beneficiaries
$1,997
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+31%
Cost per patient vs peers
$1,997 vs $1,524 avg
+28%
Brand preference vs peers
17.4% vs 13.7% avg
Brand vs Generic
83% generic
Brand: 1,773 claims · $2.4M
Generic: 8,402 claims · $219K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 996 | $1.4M |
| Rivaroxaban | 183 | $300K |
| Sacubitril/Valsartan | 153 | $251K |
| Evolocumab | 104 | $129K |
| Empagliflozin | 59 | $95K |
| Alirocumab | 47 | $60K |
| Metoprolol Succinate | 1,469 | $32K |
| Ticagrelor | 31 | $27K |
| Dapagliflozin Propanediol | 19 | $24K |
| Dronedarone Hcl | 11 | $24K |
| Atorvastatin Calcium | 1,062 | $16K |
| Icosapent Ethyl | 18 | $16K |
| Icosapent Ethyl | 27 | $15K |
| Rosuvastatin Calcium | 644 | $13K |
| Ezetimibe | 313 | $12K |
Prescribing Profile
61
Unique Drugs
$2.1M
Patient Profile
76
Avg Age
49%
Female
1.54
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data